Xiao-Tang Kong

Assistant Clinical Professor, Neurology
School of Medicine

M.D., Keck School of Medicine, University of Southern California, 2008

Ph.D., The University of Tokyo, 1996

M.D., Beijing Capital University of Medical Science, 1994

Phone: (714) 456-6208
Fax: (714)-456-6894
Email: xkong@uci.edu

University of California, Irvine
200 S. Manchester Ave., Suite 206
Mail Code: 4280
Irvine, CA 92868

Publications Kong XT, Fu D, Carrillo J, and Bota D. Assessing the beneficial impacts of the neuro-oncology hospitalist model: A pilot run at UC Irvine. Neuro Oncology 2016;18 (suppl 6): vi160-vi161.

Kong XT, Alexandru D and Bota D. Epidemiology of Central Nervous System Metastases. In: Brain Metastases from Primary Tumors. Edited by Hayat MA, Elsevier, 2014:11-24.

Clayton E, Madamba J, Kong, XT and Braskett M. Successful desensitization protocol for delayed cutaneuous eruption to temozolomide. The Journal of Allergy and Clinical Immunology: In Practice. 2(3) March/April, 2014 http://dx.doi.org/10.1016/j.jaip.2014.03.016

Lisheng Ge, Neil T. Hoa, Zechariah Wilson, Gabriel Arismendi-Morillo, Xiao-Tang Kong, Rajeev B. Tajhya, Christine Beeton, and Martin R. Jadus. Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. J of International Immunopharmacology. 22 (2): 427-443, 2014

Hardy A, Prins R, Kong XT, Woodworth D, Pope W, Yong W, Cloughesy T, Liau L, and Elingson B. Enhancing tumor response using quatitative volumetry from T1 suntraction maps in malignant glioma treated with dentritic cell vaccination. Neuro Oncology 2014 Nov; 16 (Suppl 5): v 145. doi: 10.1093/neuonc/nou264.30

Xiao-Tang Kong, Stacey Green, Emese Filka, Richard Green, William Yong, Phioanh Nghiemphu, Timothy Cloughesy, Albert Lai. Phase II pilot study of VELCADE® (Bortezomib) in combination with Temozolomide and regional radiation therapy for upfront treatment of patients with newly-diagnosed glioblastoma multiforme. Neuro-Oncology 15:iii75–iii84, 2013. doi:10.1093/neuonc/not179

Xiao-Tang Kong, Tom Davidson, Albert Lai, Timothy Cloughesy, Phioanh (Leia) Nghiemphu. Long term follow up after the treatment of adult intracranial or intraspinal primary pure germinoma. Neuro-Oncology 15:iii98–iii135, 2013. doi:10.1093/neuonc/not182

Fu DB, Alexandru D, Curticiu D, Kong XT and Bota D. The use of intravitreal rituximab in conjunction with systemic temozolomide and intravenous rituximab for the treatment of primary intraocular lymphoma. Hematology and Leukemia 2013. http://www.hoajonline.com/journals/pdf/2052-434X-1-1.pdf

Beverly Dan Fu, Xiao-Tang Kong and Daniela Bota. A case report of chemotherapy alone for the treatment of primary CNS T-cell lymphoma. Neuro-Oncology 14:vi65–vi85, 2012. doi:10.1093/neuonc/nos229

Kong XT, Gao H and Stanbridge EJ. Mechanism of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function. J Biol Chem. 276(35): 32990-33000, 2001.

Kong XT, Choi SH, Bessho F, Kobayashi M, Hanada R Yamamoto K and Hayashi Y. Codon 201Gly polymorphism type of the DCC gene is related to the disseminated neuroblastoma. Neoplasia, 3(4): 267-272, 2001.

Choi SH, Kong XT, Taki T, Tsuchida Y, Kawaguchi H, Kato H, Hanada R, Look AT and Hayashi Y. Reduced or absent expression and codon 201 polymorphism of DCC gene in rhabdomyosarcoma and Ewing’s sarcoma/PNET family. Int J Mol Med, 6: 463-467, 2000.

Aurelio ON, Kong XT, Gupta S, and Stanbridge EJ. p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines. Mol. Cell. Biol. 20(3): 770-778, 2000.

Kong XT, Valentine VA, Rowe ST, Valentine MB, Ragsdale ST, Jones BG, Wilkinson DA, Brodeur GM, Cohn SL and Look AT. Lack of Homozygous inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. Neoplasia, 1(1): 80-89, 1999.

Kong XT, Choi SH, Inoue A, Takita J, Yokota J, Hanada R, Yamamoto K, Bessho F, Yanagisawa M, Hayashi Y. Alterations of the tumour suppressor gene DCC in neuroblastoma. Eur J Cancer, 33(12): 1962-1965, 1997.

Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H, Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F, Yanagisawa M and Hayashi Y. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood, 90(3): 1192-1199, 1997.

Kong XT, Choi SH, Inoue A, Xu F, Chen T, Takita J, Yokota J, Bessho F, Yanagisawa M, Hanada R, Yamamoto K, and Hayashi Y. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Cancer Res., 57(17): 3772-3778, 1997.

Kong XT, Choi SH, Takita J, Yokota J, Hanada R, Yamamoto K, Bessho F, Yanagisawa M, Hayashi Y. Alterations of the tumor suppressor gene DCC in Childhood solid tumors. J Jpn Pediatr Society (Japanese), 101: 1492-1498, 1997.

Kong XT, Zhaori GT, Wang GZ and Jiang ZF. Treatment of acute lower respiratory tract infection in children caused by respiratory syncytial virus with inhalation of aerosolized Shuanghuanglian. Chin J Pediatr (Chinese), 34 (1): 11-14, 1996.

Kong XT and Jiang ZF. Current status on ribavirin aerosol treatment of respiratory syncytial virus infection in children in the world (review). Chin J Pediatr (Chinese) 131(2): 119 -121, 1993.

Kong XT, Fang HT, Jiang GQ, Zhai SZ, O' Connell DL and Brewster DR. Treatment of acute bronchiolitis with Chinese herbs. Arch Dis Child (England), 68(4): 468-471, 1993.

Kong XT, Zhaori GT, Wang GZ and Jiang ZF. Inhibition of Shanghuanglian on RSV in vitro and its antiviral mechanism. J Shuanghuanglian (Chinese) 2(1): 1-5, 1992.

Kong XT and Fang HT. Clinical analysis of 110 children with lower respiratory infection due to RSV in Harbin area. J Clin Pediatric (Chinese) 9(5): 299-301, 1991.

Kong XT and Fang HT. Rapid diagnosis of RSV infection by MACEIA. J Harbin Med Univ (Chinese) 23(3): 172-174, 1989.
American Academy of Neurology
Society of Neuro-Oncology
Chinese American Neurological Association
Other Experience Postdoctoral Researcher
UC Irvine, Microbiology and Molecular Genetics 1998—2001

Postdoctoral Researcher
St. Jude Children's Research Hospital 1997—1998

Link to this profile http://www.faculty.uci.edu/profile.cfm?faculty_id=6303
Last updated 01/01/2017